STOCK TITAN

Chemours Co (CC) CEO Denise Dignam purchases 3,378 shares at $14.95

(Neutral)
(Positive)
Form Type
4

Rhea-AI Filing Summary

Chemours Co Chief Executive Officer and director Denise Dignam purchased 3,378 shares of Chemours common stock on 2026-08-11 at $14.95 per share in an open-market transaction. Following this trade, she directly owns a total of 339,916.3423 shares, which includes directly owned shares, restricted stock units and dividend equivalent units, with the total adjusted to correct an administrative error in prior reports.

Positive

  • None.

Negative

  • None.
Insider Dignam Denise
Role Chief Executive Officer
Bought 3,378 shs ($51K)
Type Security Shares Price Value
Purchase Common Stock F1, F2 3,378 $14.95 $51K
Holdings After Transaction: Common Stock — 339,916.3423 shares (Direct)
Footnotes (2)
  1. F1. Includes directly owned shares, restricted stock units and dividend equivalent units.
  2. F2. The total holdings have been adjusted to correct an administrative error in prior Form 4s.
Shares purchased 3,378 shares Open-market or private purchase of Chemours common stock on 2026-08-11
Purchase price $14.95 per share Price paid per share in the 2026-08-11 purchase transaction
Total direct holdings after transaction 339,916.3423 shares Direct ownership after purchase, including shares, RSUs and dividend equivalent units
restricted stock units financial
"Includes directly owned shares, restricted stock units and dividend equivalent units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend equivalent units financial
"Includes directly owned shares, restricted stock units and dividend equivalent units."
Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.
administrative error regulatory
"The total holdings have been adjusted to correct an administrative error in prior Form 4s."

FAQ

What insider transaction did Chemours (CC) CEO Denise Dignam report?

Denise Dignam reported a purchase of 3,378 Chemours common shares on 2026-08-11 at $14.95 per share in an open-market or private transaction, as reflected in a Form 4 filing.

How many Chemours (CC) shares does CEO Denise Dignam hold after this Form 4 transaction?

After the reported trade, Denise Dignam holds 339,916.3423 Chemours shares directly. This figure includes directly owned shares, restricted stock units and dividend equivalent units, and reflects an adjustment for an earlier administrative error.

Was Denise Dignam’s Chemours (CC) share purchase made under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not marked, and no footnote references a trading plan. The reported 3,378-share purchase at $14.95 is therefore not identified as occurring under a Rule 10b5-1 plan.

What was the purchase price per share in the latest Chemours (CC) insider buy?

The reported purchase price was $14.95 per Chemours share. CEO Denise Dignam acquired 3,378 shares at this per-share price in an open-market or private transaction dated 2026-08-11.

Did the Chemours (CC) Form 4 mention any correction to prior reported holdings?

Yes. A footnote states that total holdings have been adjusted to correct an administrative error in prior Form 4s. The updated figure is 339,916.3423 shares, including RSUs and dividend equivalent units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dignam Denise

(Last)(First)(Middle)
C/O THE CHEMOURS COMPANY
1007 MARKET STREET

(Street)
WILMINGTON DELAWARE 19801

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/11/2026P3,378A$14.95339,916.3423(1)(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Includes directly owned shares, restricted stock units and dividend equivalent units.
2. The total holdings have been adjusted to correct an administrative error in prior Form 4s.
/s/ Eric Stein, Attorney-in-Fact08/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)